Search research articles
Contact Us
Filters
Showing results (131-140 of 161) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2006
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group
Kaci L Osenga, Jacquelyn A Hank, Mark R Albertini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 3, 2018
Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium
A Lindsay Frazier, Sara Stoneham, Carlos Rodriguez-Galindo, et al.
Pediatric Blood & Cancer
|
December 30, 2017
Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study
Bryan J Dicken, Deborah F Billmire, Mark Krailo, et al.
The Oncologist
|
June 6, 2014
Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors
Sara J Stoneham, Juliet P Hale, Carlos Rodriguez-Galindo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2015
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model
Piotr Czauderna, Beate Haeberle, Eiso Hiyama, et al.
The Oncologist
|
February 17, 2018
Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors
Sara J Stoneham, Juliet P Hale, Carlos Rodriguez-Galindo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group
Furqan Shaikh, John W Cullen, Thomas A Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group
Katherine A Janeway, Alexander J Chou, Allen Buxton, et al.
Journal of the National Cancer Institute
|
June 26, 2024
Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report
Lenka Ilcisin, Ruxu Han, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2009
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study
Linda Granowetter, Richard Womer, Meenakshi Devidas, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 161) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2006
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group
Kaci L Osenga, Jacquelyn A Hank, Mark R Albertini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 3, 2018
Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium
A Lindsay Frazier, Sara Stoneham, Carlos Rodriguez-Galindo, et al.
Pediatric Blood & Cancer
|
December 30, 2017
Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study
Bryan J Dicken, Deborah F Billmire, Mark Krailo, et al.
The Oncologist
|
June 6, 2014
Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors
Sara J Stoneham, Juliet P Hale, Carlos Rodriguez-Galindo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 15, 2015
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model
Piotr Czauderna, Beate Haeberle, Eiso Hiyama, et al.
The Oncologist
|
February 17, 2018
Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors
Sara J Stoneham, Juliet P Hale, Carlos Rodriguez-Galindo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group
Furqan Shaikh, John W Cullen, Thomas A Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group
Katherine A Janeway, Alexander J Chou, Allen Buxton, et al.
Journal of the National Cancer Institute
|
June 26, 2024
Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report
Lenka Ilcisin, Ruxu Han, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2009
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study
Linda Granowetter, Richard Womer, Meenakshi Devidas, et al.
Page
of 17